Red

Bestqool Launches Innovative Red Light Therapy Devices for Eczema Relief

Retrieved on: 
星期五, 四月 5, 2024
Skin care, Fibroblast, Health, Certification, RLT, Psoriasis, Adenosine triphosphate, Cell, Serotonin, Patient, Photobiology, Tissue, Rosacea, Mitochondrion, Mental health, History, Red, Quality of life, Dermatitis, Itch, Keratinocyte, Acne, Skin, Pollution, Erythema, Cytokine, Irritation, ATP, Immune system, Recurrence, Fatigue, Swelling, FDA, Waste, Medical device

Bestqool's advanced red light therapy offers a non-invasive, natural solution for managing this pervasive skin issue.

Key Points: 
  • Bestqool's advanced red light therapy offers a non-invasive, natural solution for managing this pervasive skin issue.
  • Combining red light therapy with topical ointments can be a complementary approach for effective eczema treatment.
  • Bestqool's latest range of portable red light therapy devices are designed to be both convenient and effective for home use.
  • Adding red light therapy to daily care and prevention can repair both inside and outside by lowering eczema recurrence and improving the quality of life.

Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights

Retrieved on: 
星期四, 三月 28, 2024
AstraZeneca, Exercise, Fortification, New Drug Application, Patient, GBM, CRL, NDA, Menkes, Minocycline, Therapy, Marketing, Radiation, CKPT, Rosacea, Investigational New Drug, Erythema, Safety, BLA, Fortress Biotech, Food, Red, Amyloidosis, Dermatology, Carcinoma, FDA, Hyperhidrosis, Mustang Bio, Menkes disease, PDUFA, Pharmaceutical industry

MIAMI, March 28, 2024 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity holdings and dividend and royalty revenue, today announced financial results and recent corporate highlights for the full-year ended December 31, 2023.

Key Points: 
  • Lindsay A. Rosenwald, M.D., Fortress’ Chairman, President and Chief Executive Officer, said, “In 2023, we built a significant amount of momentum to position our Company to achieve multiple milestones in 2024.
  • In March 2024, the FDA accepted the NDA and has set a PDUFA goal date of November 4, 2024.
  • In December 2023, the FDA issued a complete response letter (“CRL”) for the cosibelimab BLA.
  • Fortress’ consolidated net revenue totaled $84.5 million for the full year ended December 31, 2023, which included $59.7 million in net revenue generated from our marketed dermatology products.

Red Cat Announces $2.5 Million in Contract Awards for Two NATO Allied Countries

Retrieved on: 
星期二, 三月 26, 2024
Government, Night vision, Intelligence, FIDAE, SAN, Red, Software, RCAT, Teal, Safety

SAN JUAN, Puerto Rico, March 26, 2024 (GLOBE NEWSWIRE) -- Red Cat Holdings, Inc. (Nasdaq: RCAT) (“Red Cat” or the “Company”), a drone technology company integrating robotic hardware and software for military, government and commercial operations, announces a total of $2.5 million in new contract awards with two NATO allied countries.

Key Points: 
  • SAN JUAN, Puerto Rico, March 26, 2024 (GLOBE NEWSWIRE) -- Red Cat Holdings, Inc. (Nasdaq: RCAT) (“Red Cat” or the “Company”), a drone technology company integrating robotic hardware and software for military, government and commercial operations, announces a total of $2.5 million in new contract awards with two NATO allied countries.
  • As part of its expanded global sales strategy, Red Cat will provide the new customers with Teal 2 drone systems, training, and accessories with an anticipated delivery by the end of March.
  • “Our American-made, rucksack-portable drones are providing warfighters with rapidly deployed reconnaissance and situational awareness to enhance the effectiveness and safety of their operations,” said Jeff Thompson, Founder and CEO of Red Cat.
  • It is designed to support U.S. and allied military operations, public safety organizations, and government agencies in a variety of environments.

CIQ Unveils Secure Solutions for Regulated Industries at Google Cloud Next '24

Retrieved on: 
星期二, 四月 9, 2024
Cloud, Certification, GDC, Google Cloud, Government, Red Hat Enterprise Linux, Partnership, GOOGLE, Red, AI, LAS, Rocky, CentOS, CIQ, Public sector, Telecommunications, Network equipment provider

LAS VEGAS, April 9, 2024 /PRNewswire-PRWeb/ -- GOOGLE NEXT—At Google Cloud Next '24, CIQ announced an expansion of their partnership with Google Cloud, introducing new solutions for Google Distributed Cloud (GDC) tailored for highly regulated industries that have achieved Google Cloud Ready — Distributed Cloud designation. Customers with heightened security needs can now deploy securely with industry-compliant Rocky Linux environments provided by CIQ for GDC. These new offerings reflect CIQ leadership in highly secure, next-generation software infrastructure amidst a remarkable 500% surge in adoption of CIQ cloud solutions over the past year. CIQ is leading the next generation of software infrastructure for enterprises and the public sector.

Key Points: 
  • Elevating security in the cloud: Next step in companies' two-year collaboration with Google brings secure infrastructure solutions designed for regulated industries to Google Distributed Cloud.
  • LAS VEGAS, April 9, 2024 /PRNewswire-PRWeb/ -- GOOGLE NEXT—At Google Cloud Next '24 , CIQ announced an expansion of their partnership with Google Cloud, introducing new solutions for Google Distributed Cloud (GDC) tailored for highly regulated industries that have achieved Google Cloud Ready — Distributed Cloud designation.
  • CIQ and Google Cloud began working together in 2022 to provide customers with a best-in-class enterprise-grade supported experience for Rocky Linux on Google Cloud.
  • CIQ is a partner level Google Cloud partner for the build engagement model within Google Cloud Partner Advantage, leveraging close collaboration with Google Cloud product and engineering teams to accelerate customer adoption and migrations to Google Cloud.

Life Fitness Demos Symbio™, an Award-Winning Cardio Line with Next-Gen Biomechanics, to International Fitness Industry at FIBO 2024

Retrieved on: 
星期二, 四月 9, 2024
ICG, LFX, Red Dot, Partnership, Peter Hancock (professor), Risk, Connect, Product design, Research, Acquisition, Red, Fitness, Life, Athlete, Life Fitness, Digital Solutions, Running, VO2, FIBO, Collection, Hall

Life Fitness' latest innovations build on the company's legacy as a cornerstone in gyms and fitness facilities around the world.

Key Points: 
  • Life Fitness' latest innovations build on the company's legacy as a cornerstone in gyms and fitness facilities around the world.
  • At FIBO, visitors will see that passion come to life in our booth through our products and people," said Jim Pisani, CEO, Life Fitness.
  • Symbio is a catalyst for innovation not only within Life Fitness, but also for the cardio market at large.
  • "Our Life Fitness team is energized to bring Symbio to one of the largest international gatherings of fitness professionals and enthusiasts at FIBO 2024," said Dan Wille, Chief Product Officer, Life Fitness.

Quarterhill Announces Closing of Red Fox Acquisition

Retrieved on: 
星期一, 四月 8, 2024
Intelligent transportation system, Classification, Red, Acquisition, Software, Quantum, Adjustment, TSX, Lidar, Red fox

TORONTO, April 8, 2024 /PRNewswire/ - Quarterhill Inc. ("Quarterhill" or the "Company") (TSX: QTRH) (OTCQX: QTRHF), a leading provider of tolling and enforcement solutions in the Intelligent Transportation System ("ITS") industry, announces that it has completed the previously announced acquisition of Red Fox I.D.

Key Points: 
  • TORONTO, April 8, 2024 /PRNewswire/ - Quarterhill Inc. ("Quarterhill" or the "Company") (TSX: QTRH) (OTCQX: QTRHF), a leading provider of tolling and enforcement solutions in the Intelligent Transportation System ("ITS") industry, announces that it has completed the previously announced acquisition of Red Fox I.D.
  • Limited ("Red Fox").
  • Based in Haddenham, England, Red Fox is a profitable and growing provider of Automatic Vehicle Detection and Classification ("AVDC") software to the tolling industry.
  • "The Red Fox transaction met both our strategic and financial criteria for an acquisition, and we are pleased to welcome their team to Quarterhill," said Chuck Myers, CEO of Quarterhill.

Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights

Retrieved on: 
星期四, 三月 21, 2024
Research, U.S. FDA, Conference, Growth, Journey, Agreement, FY, IGA, Microbiota, Risk, New Drug Application, Patient, Food and Drug Administration, Rosacea, Hyperhidrosis, NDA, Red, News, Adjustment, Dermatology, Clinical trial, Erythema, Doxycycline, Safety, GAAP, Food, Marketing, FDA, CEA, Total, PDUFA, Pharmaceutical industry

SCOTTSDALE, Ariz., March 21, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of U.S. Food and Drug Administration (“FDA”)-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced financial results and recent corporate highlights for the full year ended December 31, 2023.

Key Points: 
  • ET to discuss the financial results and provide a business update
    SCOTTSDALE, Ariz., March 21, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of U.S. Food and Drug Administration (“FDA”)-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced financial results and recent corporate highlights for the full year ended December 31, 2023.
  • Claude Maraoui, Journey Medical’s Co-Founder, President and Chief Executive Officer, said, “2023 was a year of growth and development for Journey Medical.
  • In December 2023, Journey Medical entered into a $20.0 million credit facility with SWK Holdings Corporation (“SWK”), a specialized finance company with a focus on the global healthcare sector.
  • In July 2023, Journey Medical announced positive topline results from the two DFD-29 Phase 3 clinical trials (MVOR-1 & MVOR-2) for the treatment of rosacea.

Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea

Retrieved on: 
星期一, 三月 18, 2024
Entrepreneurship, Capsule, Patient, Food and Drug Administration, Rosacea, NDA, Red, Minocycline, Erythema, Food, Marketing, FDA, CEA, Physician, IGA, PDUFA, Pharmaceutical industry

The FDA has set a Prescription Drug User Fee Act (“PDUFA”) goal date of November 4, 2024.

Key Points: 
  • The FDA has set a Prescription Drug User Fee Act (“PDUFA”) goal date of November 4, 2024.
  • The Phase 3 clinical trials achieved all co-primary and secondary endpoints, and subjects completed the 16-week treatment with no significant safety issues.
  • DFD-29 demonstrated statistically significant superiority over both the current standard-of-care treatment, Oracea® 40 mg capsules, and placebo for Investigator’s Global Assessment (IGA) treatment success as well as the reduction in the total inflammatory lesion count in both studies.
  • For the secondary endpoint evaluating erythema (redness) associated with rosacea, DFD-29 showed a statistically significant reduction in Clinician’s Erythema Assessment (CEA) compared to placebo in both clinical trials.”

Now Shipping: CHERRY XTRFY K5V2 Compact Gaming Keyboard

Retrieved on: 
星期五, 三月 15, 2024
VIP, LAN, RGB, Gold, Red, Software, USB, Acoustics, Heart, Hertz, LED, Typesetting

KENOSHA, Wis. and AUERBACH I.D.OPF., Germany, March 15, 2024 (GLOBE NEWSWIRE) -- CHERRY XTRFY, the specialist for high-quality gaming peripherals, announces the availability of the new K5V2 keyboard – the first gaming keyboard with CHERRY’s new mechanical MX2A switches.

Key Points: 
  • KENOSHA, Wis. and AUERBACH I.D.OPF., Germany, March 15, 2024 (GLOBE NEWSWIRE) -- CHERRY XTRFY, the specialist for high-quality gaming peripherals, announces the availability of the new K5V2 keyboard – the first gaming keyboard with CHERRY’s new mechanical MX2A switches.
  • One of the smallest but most advanced gaming keyboards in the CHERRY XTRFY portfolio, the K5V2 has a footprint of just 65 percent of a conventional keyboard.
  • Gamers can also customize their own K5V2 keyboard in the CHERRY XTRFY online store using the Custom Keyboard Builder .
  • The brand-new CHERRY XTRFY K5V2 Compact Gaming Keyboard will also be there, and CHERRY XTRFY will equip the LAN event’s VIP gamers with the keyboard along with other high-quality peripherals.

Amerex Group Unveils Red Carter Swimwear's Revitalized Collection

Retrieved on: 
星期四, 三月 28, 2024
Fashion, Online Retail, Retail, Luxury, Consumer, Catalog, Women, Multimedia, Woman, Collection, Season, Red, Fashion design

Amerex Group LLC (“Amerex”) is thrilled to announce the relaunch of the iconic Red Carter swimwear brand.

Key Points: 
  • Amerex Group LLC (“Amerex”) is thrilled to announce the relaunch of the iconic Red Carter swimwear brand.
  • Collaborating with renowned swimwear designer Red Carter, Amerex presents a refreshed collection that seamlessly blends Red's unique design perspectives and years of industry expertise.
  • View the full release here: https://www.businesswire.com/news/home/20240328908642/en/
    Red Carter High Contrast Collection triangle bikini top with tie side bikini bottom.
  • I can't wait to dress all my main characters in the Red Carter label," shared Red Carter, expressing his excitement about the collaboration.